BioNexus Gene Lab Corp. (BGLC)
NASDAQ: BGLC · Real-Time Price · USD
5.70
+0.48 (9.20%)
At close: Sep 17, 2025, 4:00 PM EDT
5.52
-0.19 (-3.25%)
After-hours: Sep 17, 2025, 6:47 PM EDT
BioNexus Gene Lab Market Cap
BioNexus Gene Lab has a market cap or net worth of $10.24 million as of September 17, 2025. Its market cap has increased by 29.53% in one year.
Market Cap
10.24M
Enterprise Value
7.70M
1-Year Change
29.53%
Ranking
Category
Stock Price
$5.70
Market Cap Chart
Since September 16, 2020, BioNexus Gene Lab's market cap has decreased from $42.12M to $10.24M, a decrease of -75.69%. That is a compound annual growth rate of -24.62%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 16, 2025 | 9.38M | 86.61% |
Dec 31, 2024 | 5.03M | -46.33% |
Dec 29, 2023 | 9.36M | -94.33% |
Dec 30, 2022 | 165.03M | -54.75% |
Dec 31, 2021 | 364.69M | 54.35% |
Dec 31, 2020 | 236.28M | 460.98% |
Sep 16, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Linde | 226.03B |
BHP Group | 136.73B |
Rio Tinto Group | 106.63B |
The Sherwin-Williams Company | 89.53B |
Newmont | 86.76B |
Southern Copper | 86.24B |
Ecolab | 77.32B |
Agnico Eagle Mines | 76.98B |